Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-07-2019
AUM:
₹ 840.48 Cr
Expense Ratio
2.32%
Benchmark
BSE Healthcare TRI
ISIN
INF209KB1N91
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Mr. Dhaval Shah
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 2.75 | 21.89 | 17.48 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
31.06
Last change
-0.73 (-2.3503%)
Fund Size (AUM)
₹ 840.48 Cr
Performance
20.45% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Fund Manager
Mr. Dhaval Shah
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 11.69 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 7.65 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.32 |
| ABBOTT INDIA LIMITED EQ | 6.92 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 5.41 |
| FORTIS HEALTHCARE LIMITED. EQ | 4.99 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.52 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 3.96 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 3.66 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.64 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 95.87 |
| Financial Services | 1.66 |
| Chemicals | 0.92 |